Replimune (REPL) Retained Earnings (2018 - 2026)
Replimune (REPL) reported Retained Earnings of $5.4 million for Q1 2026, up 100.57% on a YoY basis from $2.7 million in Q1 2025, and up 100.45% sequentially from -$1.2 billion in Q4 2025.
Replimune (REPL) Retained Earnings (2018 - 2026) Analysis & Trends
Replimune (REPL) has 9 years of Retained Earnings data on file, last reported at $5.4 million in Q1 2026.
- For the quarter ending Q1 2026, Retained Earnings rose 100.57% year-over-year to $5.4 million; the trailing twelve-month figure through Mar 2026 stood at $5.4 million (up 100.57% YoY), and the FY2026 full-year result was $5.4 million, up 100.57% from the prior year.
- Retained Earnings climbed to $5.4 million in Q1 2026, from -$1.2 billion in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $1.4 billion in Q3 2025 to a low of -$1.2 billion in Q4 2025.
- A 5-year average of -$53.8 million and a median of $4.2 million in 2025 frame the typical range for Retained Earnings.
- Across the five-year window, Retained Earnings surged 8640455.56% in 2022 and slumped 19638.19% in 2025, its largest moves.
- Tracing REPL's Retained Earnings over 5 years: stood at $1.0 billion in 2022, then gained by 3.42% to $1.1 billion in 2023, then tumbled by 99.42% to $6.2 million in 2024, then tumbled by 19409.99% to -$1.2 billion in 2025, then surged by 100.45% to $5.4 million in 2026.
- Business Quant data shows REPL's Retained Earnings at $5.4 million in Q1 2026, -$1.2 billion in Q4 2025, and $1.4 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | Replimune | 970.73 Mn | 970.73 Mn | - | 5.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.40 Mn |
| Dec 31, 2025 | -1.19 Bn |
| Sep 30, 2025 | 1.38 Bn |
| Jun 30, 2025 | 4.24 Mn |
| Mar 31, 2025 | -948.58 Mn |
| Dec 31, 2024 | 6.16 Mn |
| Sep 30, 2024 | -808.10 Mn |
| Jun 30, 2024 | -755.05 Mn |
| Mar 31, 2024 | 4.86 Mn |
| Dec 31, 2023 | 1.06 Bn |
| Sep 30, 2023 | -595.09 Mn |
| Jun 30, 2023 | -535.04 Mn |
| Mar 31, 2023 | 5.73 Mn |
| Dec 31, 2022 | 1.03 Bn |
| Sep 30, 2022 | 777.65 Mn |
| Jun 30, 2022 | -353.46 Mn |
| Mar 31, 2022 | -973,000.00 |
| Dec 31, 2021 | -279.51 Mn |
| Sep 30, 2021 | 9,000.00 |
| Jun 30, 2021 | -220.48 Mn |